Top Predictions for Biotech in 2025
Summary: In a Fireside Chat during the 2025 J.P. Morgan Healthcare Conference, Catalent President & CEO Alessandro Maselli shared his predictions for 2025, and his thoughts on the top risks and opportunities in Biotech with Endpoints News Editor John Carroll. A wide range of topics were covered, including the outlook for biotech funding and dealmaking, what the new U.S. administration means to the biopharma industry, the evolving role of speed, technology and AI in healthcare; and insights into the evolving CDMO market. If you missed this insightful discussion on what may impact the industry in the year ahead, now is your chance to view it.
Click below to watch the video of this conversation, certain to leave you with some intriguing takeaways.